$ Value
$113K
Shares
3,870
Price
$29
Filed
Apr 15
Insider
Name
Basho Chandan
Title
COO and CFO
CIK
0001929126
Roles
Transaction Details
Transaction Date
2026-04-14
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
167,765
Footnotes
Represents the surrender of shares to offset against tax withholding obligations associated with certain shares of restricted stock that vested on April 14, 2026. | Includes 30,404 shares of unvested restricted stock, which will vest in two equal annual installments on May 16, 2026 and 2027 (subject to continuous employment with the Issuer). Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 15,604 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.
Filing Info
Basho Chandan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-14 | ASTH | F | $113K |
| 2026-04-02 | ASTH | F | $52K |
| 2026-03-05 | ASTH | F | $31K |
| 2025-10-02 | ASTH | F | $55K |
| 2025-09-05 | ASTH | F | $50K |
| 2025-05-16 | ASTH | F | $273K |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-02 |